US Acts to Fast-track New Drugs
Merck Announces Robust Integrated Pipeline With More Than 20 Medicines and Vaccines in Late-Stage Development
Top Pharmaceutical and Biotech Companies Face Slow Down in Sales Growth Over 2008–14
GlaxoSmithKline Responds to US Senate Committee on Finance Report on Avandia
Boehringer Ingelheim’s Pradaxa Will Garner Blockbuster Sales of $1.3 Billion by 2018 in the Atrial Fibrillation Drug
Posted in Industry Stories
You must be logged in to post a comment.
SUBSCRIBE
SUBSCRIBE